Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Orion Group Holdings Inc (ORN)

Orion Group Holdings Inc (ORN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks See Support as Bond Yields Fall on Powell Comments

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. US stocks this morning...

$SPX : 5,509.01 (+0.62%)
SPY : 549.01 (+0.67%)
$DOWI : 39,331.85 (+0.41%)
DIA : 393.29 (+0.47%)
$IUXX : 20,011.89 (+1.01%)
QQQ : 486.98 (+1.05%)
ZNU24 : 109-135 (-0.04%)
STX : 103.13 (+0.67%)
SMCI : 837.17 (+3.06%)
SCHW : 74.15 (+0.99%)
TSLA : 231.26 (+10.20%)
ONON : 37.22 (-2.13%)
Stocks Mixed as US PPI Report Signals Sticky Price Pressures

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.02%. US stocks this morning...

$SPX : 5,509.01 (+0.62%)
SPY : 549.01 (+0.67%)
$DOWI : 39,331.85 (+0.41%)
DIA : 393.29 (+0.47%)
$IUXX : 20,011.89 (+1.01%)
QQQ : 486.98 (+1.05%)
ZNU24 : 109-135 (-0.04%)
WBA : 11.57 (-0.09%)
TSLA : 231.26 (+10.20%)
ONON : 37.22 (-2.13%)
STLA : 19.66 (-1.40%)
ORN : 8.59 (-0.12%)
S&P Futures Climb Ahead of Key U.S. Inflation Data, Intel Surges on Upbeat Earnings

September S&P 500 futures (ESU23) are trending up +0.46% this morning as market participants braced for a reading on the Federal Reserve’s preferred inflation gauge.

ESU23 : 4,491.72s (-0.32%)
INTC : 31.07 (+0.75%)
META : 509.50 (+0.96%)
ABBV : 165.96 (-2.59%)
EBAY : 53.25 (+1.08%)
CMG : 61.40 (-0.66%)
XOM : 114.18 (-0.68%)
PG : 163.90 (+0.73%)
AON : 295.57 (+0.71%)
CL : 96.12 (+0.61%)
STAN.L.EB : 715.000 (-2.03%)
IAG.L.IX : 164.700 (-0.03%)
Orion Group Holdings, Inc. Reports Second Quarter 2022 Results

HOUSTON, July 27, 2022 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today...

ORN : 8.59 (-0.12%)
ORYZON Collaborates with the CMT Research Foundation in the US

To explore Oryzon’s HDAC6 inhibitors on Charcot-Marie-Tooth diseaseCMTRF to provide funding for in vivo efficacy tests in CMT preclinical model MADRID and...

ORN : 8.59 (-0.12%)
ORYZON Reports Results and Corporate Update for Half-Year Ending June 30, 2022

Oryzon invests $8.1 million in R&D in the first half 2022...

ORN : 8.59 (-0.12%)
ORYZON Enters Cooperative Research and Development Agreement (CRADA) with U.S. National Cancer Institute to Develop Iadademstat in Different Cancers

Oryzon and NCI will collaborate to assess the safety and efficacy of iadademstat in oncology patients with different hematological and solid tumors ...

ORN : 8.59 (-0.12%)
Orion Group Holdings, Inc. Schedules 2022 Second Quarter Results News Release for Wednesday, July 27th and Conference Call for Thursday, July 28th

HOUSTON, July 18, 2022 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company"), a leading specialty construction company, today...

ORN : 8.59 (-0.12%)
ORYZON at EHA-2022: Iadademstat 42-month ALICE Data Demonstrate Robust Efficacy in Combination with Azacitidine in AML

81% of evaluable patients achieved an objective responseDeep responses: 64% are CR/CRi, of which 86% achieved transfusion independenceRapid and durable...

ORN : 8.59 (-0.12%)
ORYZON Announces FDA Orphan Drug Designation Granted to Iadademstat for Treatment of Small Cell Lung Cancer

Now has orphan drug designation for SCLC and AML MADRID, Spain and CAMBRIDGE, Mass., June 08, 2022 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN...

ORN : 8.59 (-0.12%)

Barchart Exclusives

Is This Copper Mining Stock a Buy for Its Fat Dividend?
Southern Copper has a higher dividend yield compared to other copper mining companies. However, its valuations are also on the higher side, making a closer examination of the risk-reward necessary for prospective investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar